Literature DB >> 18761350

Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination.

Eva Csosz1, Peter Bagossi, Zoltan Nagy, Zsuzsanna Dosztanyi, Istvan Simon, Laszlo Fesus.   

Abstract

Tissue transglutaminase (TG2) catalyzes the Ca(2+)-dependent posttranslational modification of proteins via formation of isopeptide bonds between their glutamine and lysine residues. Although substrate specificity of TG2 has been studied repeatedly at the sequence level, no clear consensus sequences have been determined so far. With the use of the extensive structural information on TG2 substrate proteins listed in TRANSDAB Wiki database, a slight preference of TG2 for glutamine and lysine residues situated in turns could be observed. When the spatial environment of the favored glutamine and lysine residues was analyzed with logistic regression, the presence of specific amino acid patterns was identified. By using the occurrence of the predictor amino acids as selection criteria, several polypeptides were predicted and later identified as novel in vitro substrates for TG2. By studying the sequence of TG2 substrate proteins lacking available crystal structure, the strong favorable influence on substrate selection of the presence of substrate glutamine and lysine residues in intrinsically disordered regions could also be revealed. The collected structural data have provided novel understanding of how this versatile enzyme selects its substrates in various cell compartments and tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18761350     DOI: 10.1016/j.jmb.2008.08.026

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis.

Authors:  F Rossin; M D'Eletto; L Falasca; S Sepe; S Cocco; G M Fimia; M Campanella; P G Mastroberardino; M G Farrace; M Piacentini
Journal:  Cell Death Differ       Date:  2014-07-25       Impact factor: 15.828

Review 2.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

3.  Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.

Authors:  Camilla Lund Nikolajsen; Thomas F Dyrlund; Ebbe Toftgaard Poulsen; Jan J Enghild; Carsten Scavenius
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

4.  Functional and Structural Characterization of the Antiphagocytic Properties of a Novel Transglutaminase from Streptococcus suis.

Authors:  Jie Yu; Yaya Pian; Jingpeng Ge; Jie Guo; Yuling Zheng; Hua Jiang; Huaijie Hao; Yuan Yuan; Yongqiang Jiang; Maojun Yang
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

5.  Transglutaminase-mediated semen coagulation controls sperm storage in the malaria mosquito.

Authors:  David W Rogers; Francesco Baldini; Francesca Battaglia; Maria Panico; Anne Dell; Howard R Morris; Flaminia Catteruccia
Journal:  PLoS Biol       Date:  2009-12-22       Impact factor: 8.029

Review 6.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

7.  Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies.

Authors:  Zoltán Nemes; Goran Petrovski; Maarten Aerts; Kjell Sergeant; Bart Devreese; László Fésüs
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

8.  Aberrant calcium signaling by transglutaminase-mediated posttranslational modification of inositol 1,4,5-trisphosphate receptors.

Authors:  Kozo Hamada; Akiko Terauchi; Kyoko Nakamura; Takayasu Higo; Nobuyuki Nukina; Nagisa Matsumoto; Chihiro Hisatsune; Takeshi Nakamura; Katsuhiko Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

9.  Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.

Authors:  Kévin Baranger; Marie-Louise Zani; Valérie Labas; Sandrine Dallet-Choisy; Thierry Moreau
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

10.  Identification of transglutaminase reactive residues in human osteopontin and their role in polymerization.

Authors:  Brian Christensen; Elias D Zachariae; Carsten Scavenius; Morten Thybo; Morten M Callesen; Søren Kløverpris; Claus Oxvig; Jan J Enghild; Esben S Sørensen
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.